[HTML][HTML] Changing landscape of systemic therapy in biliary tract cancer

E Woods, D Le, BK Jakka, A Manne - Cancers, 2022 - mdpi.com
Simple Summary Cancers from the bile ducts and gall bladder are lethal. Cure by surgery is
not possible in most of these tumors as they are often identified in later stages. Unlike other …

Changing Landscape of Systemic Therapy in Biliary Tract Cancer.

E Woods, BK Jakka, A Manne - Cancers, 2022 - europepmc.org
Biliary tract cancers (BTC) are often diagnosed at advanced stages and have a grave
outcome due to limited systemic options. Gemcitabine and cisplatin combination (GC) has …

Changing Landscape of Systemic Therapy in Biliary Tract Cancer

E Woods, D Le, BK Jakka, A Manne - Cancers, 2022 - pubmed.ncbi.nlm.nih.gov
Biliary tract cancers (BTC) are often diagnosed at advanced stages and have a grave
outcome due to limited systemic options. Gemcitabine and cisplatin combination (GC) has …

Changing Landscape of Systemic Therapy in Biliary Tract Cancer

E Woods, D Le, BK Jakka, A Manne - Cancers, 2022 - search.proquest.com
Biliary tract cancers (BTC) are often diagnosed at advanced stages and have a grave
outcome due to limited systemic options. Gemcitabine and cisplatin combination (GC) has …

Changing Landscape of Systemic Therapy in Biliary Tract Cancer

E Woods, D Le, BK Jakka, A Manne - Cancers, 2022 - ohiostate.elsevierpure.com
Biliary tract cancers (BTC) are often diagnosed at advanced stages and have a grave
outcome due to limited systemic options. Gemcitabine and cisplatin combination (GC) has …

Changing Landscape of Systemic Therapy in Biliary Tract Cancer.

E Woods, D Le, BK Jakka, A Manne - Cancers, 2022 - search.ebscohost.com
Abstract Simple Summary: Cancers from the bile ducts and gall bladder are lethal. Cure by
surgery is not possible in most of these tumors as they are often identified in later stages …

[HTML][HTML] Changing Landscape of Systemic Therapy in Biliary Tract Cancer

E Woods, D Le, BK Jakka, A Manne - Cancers, 2022 - ncbi.nlm.nih.gov
Biliary tract cancers (BTC) are often diagnosed at advanced stages and have a grave
outcome due to limited systemic options. Gemcitabine and cisplatin combination (GC) has …